D. E. Shaw & Co., Inc. Allakos Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Allakos Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 32,363 shares of ALLK stock, worth $30,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,363

Holding current value

$30,421

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.92 $181,760 - $309,666	-336,594 Reduced 91.23%	32,363 $21,000
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $133,566 - $193,670	-133,566 Reduced 26.58%	368,957 $368,000
Q1 2024 May 15, 2024	BUY	$1.02 - $3.23 $120,017 - $380,054	117,664 Added 30.57%	502,523 $633,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $62,092 - $114,798	-36,100 Reduced 8.58%	384,859 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$2.13 - $5.55 $108,106 - $281,684	-50,754 Reduced 10.76%	420,959 $955,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $531,370 - $774,915	147,603 Added 45.54%	471,713 $2.06 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $399,353 - $768,059	92,873 Added 40.16%	324,110 $1.44 Million
Q4 2022 Feb 14, 2023	SELL	$5.66 - $8.42 $116,697 - $173,603	-20,618 Reduced 8.19%	231,237 $1.95 Million
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $3.14 Million - $6.35 Million	-1,038,102 Reduced 80.48%	251,855 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	$2.6 - $6.14 $1.49 Million - $3.52 Million	573,254 Added 79.98%	1,289,957 $4.04 Million
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $593,567 - $1.15 Million	-116,844 Reduced 14.02%	716,703 $4.09 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $7.06 Million - $92.3 Million	825,260 Added 9958.49%	833,547 $8.16 Million
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $6.05 Million - $8.73 Million	-79,099 Reduced 90.52%	8,287 $877,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $1.73 Million - $2.31 Million	20,221 Added 30.11%	87,386 $7.46 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $4.4 Million - $6.16 Million	40,079 Added 147.97%	67,165 $7.71 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.81 Million - $3.46 Million	22,697 Added 517.13%	27,086 $3.79 Million
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $3.53 Million - $6.47 Million	-80,237 Reduced 94.81%	4,389 $315,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $2.62 Million - $7.59 Million	84,626 New	84,626 $6.65 Million
Q2 2019 Aug 14, 2019	SELL	$36.0 - $44.73 $768,672 - $955,074	-21,352 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $721,484 - $1.11 Million	21,352 New	21,352 $865,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$15.6 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$5.78 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$4.7 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.3 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$2.89 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $79.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account